Other
Total neoadjuvant therapy
Total neoadjuvant therapy is an intervention with 4 clinical trials. Currently 2 active trials ongoing.
Total Trials
4
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Active Trials
2(50%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
1
25%
Ph phase_3
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Not yet recruiting2
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting250%
recruiting125%
active_not_recruiting125%
Recent Activity
2 active trials
Showing 4 of 4
recruitingnot_applicable
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
NCT06052332
not_yet_recruitingphase_2
PET/MRI in Rectal Cancer
NCT06057831
active_not_recruiting
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
NCT05674422
not_yet_recruitingphase_3
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
NCT06097416
Clinical Trials (4)
Showing 4 of 4 trials
NCT06052332Not Applicable
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer
NCT06057831Phase 2
PET/MRI in Rectal Cancer
NCT05674422
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
NCT06097416Phase 3
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 4